Actively Recruiting
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
Led by Aswan University · Updated on 2025-02-21
148
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare whether 5 μg dexmedetomidine with 25 μg fentanyl added to 0.5% hyperbaric bupivacaine as adjuvants in spinal anaesthesia in patients undergoing appendectomy could reduce intraoperative peritoneal related symptoms.
CONDITIONS
Official Title
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ASA physical status class I and II
- Age between 18 and 60 years
- Either sex
You will not qualify if you...
- ASA physical status class III and IV
- Infection at the site of injection
- Coagulopathy or use of anticoagulants
- Congenital anomalies of the lower spine
- Active disease of the central nervous system
- Allergy to local anesthetics or the adjuvants
- Complicated appendicitis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aswan University
Aswān, Aswan Governorate, Egypt, 81528
Actively Recruiting
Research Team
S
Soudy S Hammad, MD
CONTACT
A
Ahmed M Hagag, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here